Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.46 EUR | +1.80% | +9.09% | -50.66% |
05-14 | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
05-14 | Centogene N.V and Evotec SE Discovers Promising New Molecule to Treat Gaucher Disease | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.66% | 1.97B | |
+27.58% | 49.18B | |
+0.82% | 42.11B | |
+50.30% | 40.37B | |
-5.26% | 28.85B | |
+13.06% | 26.09B | |
-21.95% | 18.71B | |
+9.73% | 13.26B | |
+31.31% | 12.32B | |
+0.03% | 11.99B |
- Stock Market
- Equities
- EVT Stock
- News Evotec SE
- Transcript : Evotec SE, Nine Months 2023 Earnings Call, Nov 08, 2023